Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week

作者: Joao Paulo Maia-de-Oliveira , Bruno Lobão-Soares , Thais Ramalho , Elaine C. Gavioli , Vanessa Paula Soares

DOI: 10.1016/J.SCHRES.2014.12.035

关键词:

摘要: Abstract Recently, we found a rapid and long-lasting improvement of symptoms in schizophrenic patients on antipsychotics after single four-hour infusion sodium nitroprusside (SNP), nitric oxide (NO) donor with short half-life. This persisted for up to 4 weeks. Because these remained SNP was finished, the question arises about whether this due itself. We have now investigated SNP, alone, can produce preventive antipsychotic effects rats treated ketamine (KET). 56 adult divided into 7 groups were infused 4 mg/kg, KET 25 mg/kg, or saline as follows: group1 — saline, group2 group3 KET, group4 12 h group5 1 day group6 2 days group7 1 week SNP. The animals filmed an open field arena 30 min videos later analyzed by ANY-Maze software measure activity stereotypy. significantly prevented emergence hyperactivity induced when it administered before stereotypies KET. These findings rats, which even faster metabolic rate than humans, suggest that observed our clinical trial humans could been itself, indicate first time may present effects.

参考文章(41)
João Paulo Maia-de-Oliveira, Clarissa Trzesniak, Irismar R. Oliveira, Matthew J. Kempton, Tatiana M. N. de Rezende, Sandro Iego, Glen B. Baker, Serdar M. Dursun, João Paulo Machado-de-Sousa, Jaime E.C. Hallak, Níveis plasmáticos/séricos do óxido nítrico em pacientes com esquizofrenia: uma revisão sistemática e metanálise Revista Brasileira de Psiquiatria. ,vol. 34, ,(2012) , 10.1016/J.RBP.2012.07.001
Hope H. Wu, David K. Waid, Steven C. McLoon, Nitric oxide and the developmental remodeling of retinal connections in the brain. Progress in Brain Research. ,vol. 108, pp. 273- 286 ,(1996) , 10.1016/S0079-6123(08)62546-7
Jay E. Brenman, David S. Bredt, Nitric oxide signaling in the nervous system. Methods in Enzymology. ,vol. 269, pp. 119- 129 ,(1996) , 10.1016/S0076-6879(96)69014-4
Stephen R. Saklad, Sheri A. Thornberg, A review of NMDA receptors and the phencyclidine model of schizophrenia Pharmacotherapy. ,vol. 16, pp. 82- 93 ,(1996) , 10.1002/J.1875-9114.1996.TB02920.X
Douglas T. Hess, Sean I. Patterson, Deanna S. Smith, J. H. Pate Skene, Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide Nature. ,vol. 366, pp. 562- 565 ,(1993) , 10.1038/366562A0
Craig C. Smith, John F. Tallman, Robert M. Post, Daniel P. van Kammen, David C. Jimerson, Gerald L. Brown, Benjamin R. Brooks, William E. Bunney, An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patients. Life Sciences. ,vol. 19, pp. 131- 136 ,(1976) , 10.1016/0024-3205(76)90383-0
R. P. Ebstein, J. Biederman, R. Rimon, J. Zohar, R. H. Belmaker, Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment. Psychopharmacology. ,vol. 51, pp. 71- 74 ,(1976) , 10.1007/BF00426324
M Bujas-Bobanovic, D C Bird, H A Robertson, S M Dursun, Blockade of phencyclidine-induced effects by a nitric oxide donor British Journal of Pharmacology. ,vol. 130, pp. 1005- 1012 ,(2000) , 10.1038/SJ.BJP.0703406
Jaime E. C. Hallak, Joao Paulo Maia-de-Oliveira, Joao Abrao, Paulo R. Evora, Antonio W. Zuardi, Jose A. S. Crippa, Paulo Belmonte-de-Abreu, Glen B. Baker, Serdar M. Dursun, Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside A Randomized, Double-blind, Placebo-Controlled Trial JAMA Psychiatry. ,vol. 70, pp. 668- 676 ,(2013) , 10.1001/JAMAPSYCHIATRY.2013.1292
Christian Hölscher, Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity Trends in Neurosciences. ,vol. 20, pp. 298- 303 ,(1997) , 10.1016/S0166-2236(97)01065-5